This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Statement Highlights: Palliative medication management focuses on providing relief from symptoms and enhancing quality of life for people with cardiovasculardisease throughout the various stages of the disease. Decisions about initiating, adjusting.
Implementing patient-centered palliative care therapies, including prescribing, adjusting or discontinuing medications as needed, may help control symptoms and improve quality of life for people with heart disease, according to "Palliative Pharmacotherapy for CardiovascularDisease," a new scientific statement from the American Heart Association, published (..)
BackgroundIt is well known that abnormal dietary behavior increases the risk for cardiovasculardisease especially if the person is depressed and/or anxious. The masking mediating effect of abnormal dietary behavior between depression/anxiety and QoL was stronger for patients in unhealthy families.
Given the increasing global incidence of both PD and AS, which adversely affects patients’ quality of life and longevity, further investigation into the interplay between PD and AS is of substantial clinical importance. Chronic inflammation induced by PD may promote the onset and progression of AS through multiple mechanisms.
milla1cf Thu, 05/16/2024 - 15:35 May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive investigation to assess the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia.
BackgroundHeart failure (HF), a core component of cardiovasculardiseases, is characterized by high morbidity and mortality worldwide. We hope to identify high-risk patients for early intervention to reduce the incidence of HF and improve their quality of life.
Cardiovasculardisease (CVD) represents the leading cause of mortality and disability all over the world. Identifying new targeted therapeutic approaches has become a priority of biomedical research to improve patient outcomes and quality of life.
ObjectiveThis study aimed to evaluate the integration of the Hospital-Community-Home (HCH) model with the Self-Mutual-Group (SMG) health management model for high-risk populations with cardiovasculardisease in the Yuhua community of Shijiazhuang city.
Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovasculardiseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a risk factor.
In these patients, limb symptoms may reduce quality of life, and the devastating outcome of limb amputation results in social and economic burdens for both patient and family.
Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovasculardisease (CVD). Elucid has announced it received 510(k) clearance from the U.S.
Endothelial function is critical as an indicator of cardiovascular health, with impaired FMD associated with increased cardiovasculardisease risk. While this percentage may seem small, population-based research indicates that each 1% increase in FMD correlates with approximately a 13% reduction in cardiovasculardisease risk.
Its impact on cardiovascular health is becoming increasingly evident, influencing diagnosis, treatment, and monitoring of cardiovasculardiseases. The aim of this thematic collection is to gather high-quality articles that contribute to the advancement of knowledge on the use of AI in cardiovascular health.
TAVR outcomes, with respect to post-surgical functional capacity and quality of life, have also been found to be improved, especially when combined with cardiac rehabilitation (CR).
It worsens the quality of life of patients, leads to an increase in the mortality rate because of its association with a high risk of thromboembolic complications. Atrial fibrillation (AF) is the most common heart rhythm disorder in clinical practice.
Clinicians working with older patients have witnessed firsthand how polypharmacy can complicate both their care and diminish quality of life. 3 Older patients with known cardiovasculardisease are taking an average of 11 medications.1 All are members of ACC’s Cardiovascular Team Member Section.
Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. It is the third most common cardiovasculardisease [2]. Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges.
As the yearly conference of the Heart Failure Association of the ESC, its overarching goal is to enhance the quality of life and extend longevity by advancing prevention, diagnosis, and treatment of heart failure. This theme will highlight the role of cardiovasculardisease in the broader scope of global health.
Cardiovasculardiseases pose a major threat to human life, functional activity, and quality of life. Once the disease is present, patients can experience varying degrees of problems or limitations on three levels: physical, psychological, and social.
It proposes that only by using technology can a preventative approach to healthcare become more prevalent globally; this would reduce the number of people in acute care, thereby minimizing the cost of healthcare and maximizing patient experience and quality of life. 1] Kokkinos P, Faselis C, et al.
Its impact on cardiovascular health is becoming increasingly evident, influencing diagnosis, treatment, and monitoring of cardiovasculardiseases. The aim of this thematic collection is to gather high-quality articles that contribute to the advancement of knowledge on the use of AI in cardiovascular health.
Regular exercise, a balanced diet, and lifestyle choices such as not smoking and managing stress are all crucial for achieving and maintaining optimal cardiovascular health. By prioritizing cardiovascular health, individuals can improve their quality of life and longevity. Why is cardiovascular health important?
These findings have significant implications for public health policies and dietary guidelines, emphasizing the need for early intervention to promote heart health and prevent cardiovasculardiseases.
With this milestone, more patients now have access to a treatment option to help reduce their heart failure symptoms and improve their quality of life when medications alone are not enough.” The announcement noted that this procedure also marks the first Barostim implant for CVRx on the home front.
Cardiovasculardisease remains a leading cause of mortality worldwide. million people in the United States currently have one or more forms of cardiovasculardisease (CVD). Due to the prevalence of cardiovasculardisease, there are continuous advancements in cardiac surgery techniques.
These cutting-edge modalities not only enhance diagnostic precision but also facilitate more targeted and effective treatment strategies, improving survival rates and quality of life for countless women worldwide.
These cutting-edge modalities not only enhance diagnostic precision but also facilitate more targeted and effective treatment strategies, improving survival rates and quality of life for countless women worldwide.
Introduction Hypertension is the leading modifiable risk factor for cardiovasculardisease and is implicated in half of all strokes and myocardial infarctions. One-third of the adults in Scotland have hypertension yet only a quarter of them have their blood pressure (BP) controlled to target (<140/90 mm Hg).
Background:Coronary artery disease (CAD) exerts a considerable impact on mortality from cardiovasculardisease. Circulation, Volume 150, Issue Suppl_1 , Page A4122256-A4122256, November 12, 2024. Approximately half of patients with CAD initially present with angina pectoris. were women, and the median age was 61 years.
Outcomes included health-related quality of life (HRQoL) at 90-180 days post-stroke/TIA; and all-cause mortality and hospital readmissions (all-cause, cardiovasculardisease) within 1 year post-stroke/TIA.
Furthermore, carrying excess weight can also have detrimental effects on mental health as individuals may experience low self-esteem, body image issues, depression, and a reduced quality of life. The Rise of Weight Loss Drugs The rise of weight loss drugs has brought with it a promising solution in the battle against obesity.
OSA disproportionately affects the 92 million Americans living with cardiovasculardisease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY.
Looking Forward: Embrace Evidenced Based Cardiometabolic Care for Better Health By prioritizing practical, evidence-based strategies and fostering a collaborative, patient-centered approach, healthcare providers can significantly improve the management of cardiometabolic diseases and enhance the quality of life for their patients.
IntroductionPatients with cognitive impairment often have a history of cardiovasculardisease (CVD) or multiple cardiovascular risk factors (CRFs) such as hypertension, obesity, and hypercholesterolemia. The literature reports that CVD with CRFs may increase the risk of developing vascular dementia and Alzheimer’s Disease.
With this milestone, more patients now have access to a treatment option to help reduce their heart failure symptoms and improve their quality of life when medications alone are not enough.” The announcement noted that this procedure also marks the first Barostim implant for CVRx on the home front.
Cardiovasculardiseases vary widely, so personalized care is critical for improving outcomes and patient satisfaction. Personalized treatment in cardiology has become a cornerstone of modern healthcare, allowing doctors to tailor interventions to each patient’s unique needs.
Other studies have also unearthed more intricate connections which suggests that physiological conditions, underpinned by biological and chemical factors, may also play a pivotal role in influencing cardiovasculardisease (CVD). In 2021 alone, CVD accounted for over 900,000 deaths in the U.S. and approximately 19.91 million globally.
Although not generally considered a condition that can kill you, it can certainly impact your quality of life and limit the activities you do on a daily basis. Type 2 Diabetes When it comes to the increasing the risk of major chronic diseases such as cardiovasculardisease, many cancers and dementia, type 2 diabetes plays a huge role.
Healthrelated quality of life (HRQOL) has been inversely associated with multimorbidity but is understudied in lower and middleincome countries. BackgroundMultimorbidity is increasingly prevalent in lower and middleincome countries.
Cardiovasculardiseases (CVDs), characterized by a high incidence rate and high mortality, have become the leading cause of death globally. CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. In China, the death rate of CVDs ranks the first in all major diseases.
Imagine a future where a silent, undetected heart condition is caught before it turns into a life-threatening event a future where artificial intelligence (AI) -powered insights alert clinicians to warning signs long before symptoms appear. Cardiovasculardisease (CVD) remains the leading cause of death in the U.S.
Cardiovasculardisease (CVD) remains the leading cause of death worldwide, imposing a major burden on morbidity, quality of life, and societal costs, making prevention of CVD a top public health priority.
Similar patterns have been observed for cardiovasculardisease and also cancer. Longer life. Less major diseases earlier in life. 2 [link] 3 Physical activity patterns and biomarkers of cardiovasculardisease risk in hunter-gatherers. The relationship is clear. More movement. Am J Hum Biol.
Background:Notable racial and ethnic disparities exist in cardiovasculardisease (CVD) and stroke epidemiology; however, few studies have assessed the disparate quality of life (QOL) among individuals living with CVD, stroke, or both. Stroke, Volume 55, Issue Suppl_1 , Page AWP97-AWP97, February 1, 2024.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content